JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
19/12/16 - 10:00
Co-optation of a Director (333.18 KB)
10/11/16 - 1:00
DIASORIN GROUP REPORTS CONTINUED GROWTH IN REVENUES AND PROFITABILITY IN THE THIRD QUARTER 2016 (1.05 MB)
02/11/16 - 1:00
DIASORIN LAUNCHES ITS FIRST MOLECULAR TEST WITH THE NEW BUSINESS DIVISION, DIASORIN MOLECULAR: THE NEW SIMPLEXA C. DIFFICILE DIRECT MOLECULAR TEST (141.53 KB)
30/08/16 - 2:00
DiaSorin and Beckman Coulter form strategic partnership to bring the LIAISON XL hepatitis and HIV products to the U.S. market (404.63 KB)
22/08/16 - 2:00
DIASORIN PARTNERS WITH HHS TO FACE THE ZIKA EMERGENCY (158.39 KB)
04/08/16 - 2:00
The Board of Directors approves results for H1'16 (697.16 KB)
28/07/16 - 2:00
DiaSorin starts selling Vitamin D in Japan (724.4 KB)
14/07/16 - 2:00
DiaSorin increases diagnostic test menu for molecular screening of Acute Myeloid Leukemia (278.18 KB)
10/06/16 - 2:00
Weekly report treasury shares buy-back (289.83 KB)
10/06/16 - 2:00
Conclusion buy-back plan (367.77 KB)
07/06/16 - 2:00
DiaSorin launches the new Helicobacter pylori IgG CLIA test (518.61 KB)
03/06/16 - 2:00
Weekly report treasury shares buy-back (290.21 KB)
30/05/16 - 2:00
Notice filing By-Laws and publication operating procedures for loyalty shares (277.79 KB)
27/05/16 - 2:00
Weekly report treasury shares buy-back (289.34 KB)
20/05/16 - 2:00
Weekly report treasury shares buy-back (290.09 KB)
13/05/16 - 2:00
Acquisition of Focus Diagnostics' Molecular and Immunoassay Product Business (350.22 KB)
12/05/16 - 2:00
Start up treasury shares buy-back plan (305.9 KB)
09/05/16 - 2:00
The Board of Directors approves the results for Q1'16 (632.78 KB)
28/04/16 - 2:00
Shareholders' Meeting FY 2015 (365.15 KB)
30/03/16 - 2:00
DiaSorin to acquire Focus Diagnostics' Molecular and Immunoassay Product Business (133.62 KB)
09/03/16 - 1:00
The Board of Directors approves the results for FY'15 (785.08 KB)
20/12/12 - 1:00
Shareholders' meeting (55.42 KB)
07/11/12 - 1:00
The BoD approves Q3'12 results (280.42 KB)
03/08/12 - 2:00
The BoD approves H1'12 results (279.41 KB)
30/07/12 - 2:00
DiaSorin in India: JV with Trivitron Healthcare (56.16 KB)
27/06/12 - 2:00
Notification of changes in share capital (335.97 KB)
11/05/12 - 2:00
The BoD approves Q1'12 results (122.04 KB)
04/05/12 - 2:00
NorDiag acquisition (88.87 KB)
23/04/12 - 2:00
2011 statutory financial statement approval (182.29 KB)
10/04/12 - 2:00
Measles and Mumps IgM on LIAISON (available outside the US and Canada only) (43.59 KB)
02/04/12 - 2:00
Helicobacter Pylori on stool on LIAISON (available outside the US and Canada only) (43.85 KB)
30/03/12 - 2:00
Financial calendar update (176.51 KB)
22/03/12 - 1:00
Stock options to employees (175.38 KB)
12/03/12 - 1:00
Agreement with Sonic Healthcare on Vitamin D (179.85 KB)
09/03/12 - 1:00
The BoD approves FY 2011 results (357.11 KB)
07/03/12 - 1:00
Notification of changes in share capital (46.84 KB)
17/02/12 - 1:00
DiaSorin became a member of the ISBT (178.96 KB)
09/02/12 - 1:00
Notice of change in share capital (46.97 KB)
02/02/12 - 1:00
FDA clearance for 25 OH Vitamin D on LIAISON (180.35 KB)
27/01/12 - 1:00
2012 Financial calendar update (177.74 KB)
25/01/12 - 1:00
Dividend distribution in June (115.61 KB)
19/01/12 - 1:00
Prize for best Italian Company in R&D in the UK (183.95 KB)
13/01/12 - 1:00
2012 Financial calendar (176.51 KB)
12/01/12 - 1:00